Professor David Baker, Head of Biology
Dr Baker is a leading expert on the biological basis of multiple sclerosis. He was awarded a B.Sc. (Hons) in Zoology from Bedford College and a Ph.D. from London University in Immunology/Pathology for work on immunological tolerance induction in delayed hypersensitivity of the skin. He spent six years as the Angela Limerick lecturer for multiple sclerosis research at the Hunterian Institute, The Royal College of Surgeons of England. He held a Principal Fellowship to the Institute of Ophthalmology, University College London in 1994 and became the first Senior Fellow of the Multiple Sclerosis Society, moving the Institute of Neurology, University College London in 1999. He became a senior lecturer in 2003 and got a personal chair in 2004 as Professor of Neuroimmunology. He moved to Queen Mary, University of London in the autumn of 2006. Most recently he has been involved in the understanding the involvement of the cannabinoid system in symptom control, neurodegeneration and immunity as they relate to multiple sclerosis, and his work aims at the development of agents for the treatment of chronic neurodegeneration and symptom control. Dr Baker is responsible for the animal model, in vitro pharmacology and related activities of Canbex.